Technical Analysis for RCEL - Avita Medical Limited

Grade Last Price % Change Price Change
F 19.89 -0.10% -0.02
RCEL closed down 0.1 percent on Thursday, April 22, 2021, on 70 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical RCEL trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -0.10%
Bollinger Band Squeeze Range Contraction -0.10%
NR7 Range Contraction -0.10%
Older End-of-Day Signals for RCEL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 15 hours ago
Possible Inside Day about 15 hours ago
Possible Pocket Pivot 1 day ago
Possible NR7 1 day ago
Down 1% 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avita Medical Limited Description

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Rare Diseases Clinical Research Wound Suspension Dermatology Regenerative Medicine Injuries Platform Technology Burns Aesthetics Genodermatoses Treatment Solutions Epidermolysis Bullosa Skin Chronic Wound Chronic Wounds

Is RCEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 153.55
52 Week Low 16.87
Average Volume 179,933
200-Day Moving Average 23.03
50-Day Moving Average 21.98
20-Day Moving Average 20.45
10-Day Moving Average 20.49
Average True Range 0.71
ADX 16.32
+DI 20.71
-DI 31.93
Chandelier Exit (Long, 3 ATRs ) 20.14
Chandelier Exit (Short, 3 ATRs ) 21.26
Upper Bollinger Band 21.54
Lower Bollinger Band 19.36
Percent B (%b) 0.24
BandWidth 10.65
MACD Line -0.47
MACD Signal Line -0.48
MACD Histogram 0.0057
Fundamentals Value
Market Cap 430.09 Million
Num Shares 21.6 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -690.63
Price-to-Sales 29.98
Price-to-Book 7.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.24
Resistance 3 (R3) 20.23 20.12 20.18
Resistance 2 (R2) 20.12 20.03 20.12 20.16
Resistance 1 (R1) 20.00 19.97 20.06 20.01 20.14
Pivot Point 19.89 19.89 19.92 19.89 19.89
Support 1 (S1) 19.77 19.80 19.83 19.78 19.64
Support 2 (S2) 19.66 19.74 19.66 19.62
Support 3 (S3) 19.54 19.66 19.60
Support 4 (S4) 19.55